Duke University Medical Center
Durham, North Carolina, 27705, United States
NCT Number: NCT02783755
The purpose of this study is two-fold. First, the investigator will develop a low-literacy Mobile Pain Coping Skills Training (mPCST) protocol for cancer patients with pain (i.e., therapist manual, patient manual including handouts, and the smartphone materials) as well as a beta version of the basic smartphone components with the assistance of experts in the field. Next, an iterative development design using focus groups with women who have breast cancer and pain accrued from medically underserved areas will be used to refine the developed mPCST protocol and basic smart phone components. The protocol-designed to reduce cancer pain and disability in patients with low literacy in medically underserved areas-will be delivered via tele-video conferencing sessions in the community clinic. The smartphone tools (e.g., simple text messages, images, and preloaded intervention content) will allow the intervention to extend into the patients' homes. The second study purpose is to pilot test the feasibility, acceptability, and efficacy of the developed protocol. The investigator will also obtain an estimate of the effect size of the developed protocol to decrease pain. Focus group data will be managed and evaluated in a systematic format using a grounded theory approach. Data analyses for the pilot testing period of the study will be assessed by examining accrual, attrition, and adherence to the intervention. Simple t-tests will be used to examine pre- to post-intervention differences in pain and the other outcomes of interest. There are minimal risk or safety issues related to this study.
Looking for future studies?
Notify Me21 year and older
Female
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Coping Skills Training for pain will be delivered to participants using video-conferencing
Time frame: Baseline and post intervention, approximately 60 minutes
Time frame: Baseline and Post Intervention, approximately 60 minutes
Time frame: Baseline and Post Intervention, approximately 60 minutes
Time frame: Baseline and Post Intervention, approximately 60 minutes
Time frame: Baseline and Post Intervention, approximately 60 minutes
Time frame: Baseline and Post Intervention, approximately 60 minutes
The Patient Reported Outcomes Measurement Information System (PROMIS) four-item Fatigue Scale is a self-report measure of fatigue symptoms.
Time frame: Sessions 2,3,4 and 5
Patient acceptability of mPCST will be assessed with the Client Satisfaction Questionnaire 10-item version that rates items from 1 = low acceptability and 4 = high acceptability
Time frame: Baseline and Post Intervention, approximately 60 minutes
The Functional Assessment of Cancer Therapy- General (FACT-G) will be used to assess participants' health-related quality of life. The FACT-G is a 7-item self-report measure that provides participants with a variety of symptoms and concerns.
Duke University
Other
A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04175639
Breast Cancer, Breast Diseases
Durham, North Carolina, United States
View Trial DetailsNCT06101849
Agnosia, Breast Cancer
Hamilton, Ontario, Canada
View Trial DetailsNCT04343807
Agnosia, Anaesthesia
Karachi, Sindh, Pakistan
View Trial DetailsNCT06012786
Breast Cancer, Breast Cancer Female
Istanbul, Kadıköy, Turkey (Türkiye)
View Trial Details